Cargando…
Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials
Current treatments for the symptoms of schizophrenia are only effective for positive symptoms in some individuals, and have considerable side effects that impact compliance. Thus, there is a need to investigate the efficacy of other compounds in treating both positive and negative symptoms. We condu...
Autores principales: | Clark, Samuel D., Van Snellenberg, Jared X., Lawson, Jacqueline M., Abi-Dargham, Anissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608351/ https://www.ncbi.nlm.nih.gov/pubmed/32516800 http://dx.doi.org/10.1038/s41386-020-0730-z |
Ejemplares similares
-
27.1 TRANSLATIONAL EVIDENCE OF DOPAMINE-RELATED ALTERATIONS OF BASAL GANGLIA AND THALAMO-CORTICAL NEUROCIRCUITRY IN SCHIZOPHRENIA: A FULL CLINIC-TO-BENCH-TO-CLINIC BACK-TRANSLATION
por: Van Snellenberg, Jared, et al.
Publicado: (2018) -
Medial Prefrontal Cortex Dysfunction Mediates Working Memory Deficits in Patients With Schizophrenia
por: Williams, John C., et al.
Publicado: (2022) -
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019) -
Mechanisms of Working Memory Impairment in Schizophrenia
por: Van Snellenberg, Jared X., et al.
Publicado: (2016) -
Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics
por: Abi-Dargham, Anissa
Publicado: (2021)